(Q36507652)

14 August 2017

1 reference

title

How well do rapid-acting insulins work in obese individuals? (English)

1 reference

14 August 2017

0 references

Barnett AH

1

1 reference

14 August 2017

1 July 2006

1 reference

Diabetes, Obesity and Metabolism

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

4

1 reference

14 August 2017

388-395

1 reference

Insulins today and beyond

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Insulin therapy: optimizing control in type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Current estimates of the economic cost of obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Insulin analogues: new agents for improving glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

Insulin secretion in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00525.X

10.1111/J.1463-1326.2005.00525.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16776745